结直肠癌患者组织样本中miR-548aa的表达水平。
Expression level of miR-548aa in tissue samples of patients with colorectal cancer.
作者信息
Arabzadeh AmirAhmad, Farzollahpour Morteza, Seyedsadegi Mirsalim, Pourfarzi Farhad, Ghodsinezhad Vadieh, Bandehagh Helia, Pahlavan Yasamin
机构信息
Ardabil University of Medical Sciences, Ardabil, Iran.
Iran University of Medical Sciences, Tehran, Iran.
出版信息
Mol Biol Rep. 2025 Jan 16;52(1):127. doi: 10.1007/s11033-025-10225-8.
BACKGROUND
The pathogenesis of colorectal cancer (CRC) is influenced by various risk factors, and genetic alterations in progression of colon polyps. The expression patterns of microRNA-548 (miR-548) in colorectal tissues have been sufficiently characterized. The aim of this study is to clarify the role of miR-548aa in tumorigenesis, gene targeting, predictive value and its expression levels in tumoral versus adjacent marginal tissues in CRC patients.
METHODS AND RESULTS
This study included 35 CRC patients who underwent surgery to remove their tumor tissue. Tumor samples and adjacent marginal tissue were collected and gene expression was analyzed through real-time PCR. The correlation between miR-548aa expression levels and clinical parameters were investigated. Our findings showed a significant increase in the expression of miR-548aa in tumoral tissues compared to marginal tissues (p < 0.05). The upregulation of miR-548aa was significantly detected in CRC samples, showing an area under the curve of 0.89 (p = 0.002), indicating strong sensitivity and specificity for CRC diagnosis. To prediction of miRNA target genes and construction of regulatory networks of miR-548aa, we used bioinformatics tools including TargetScan and miRDB. Protein-protein interaction (PPI) network was constructed through STRING database and visualized using Cytoscape software.
CONCLUSIONS
Dysregulation of miR-548aa is closely related to tumorigenesis in colorectal tissues, which affects disease progression and clinical outcomes. The miR-548aa can be introduced as a proposed biomolecule involved in mechanism of tumorigenesis, gene targeting and predictive value for CRC diagnosis and a target for therapeutic intervention.
背景
结直肠癌(CRC)的发病机制受多种风险因素以及结肠息肉进展过程中的基因改变影响。微小RNA-548(miR-548)在结直肠组织中的表达模式已得到充分表征。本研究的目的是阐明miR-548aa在CRC患者肿瘤发生、基因靶向、预测价值及其在肿瘤组织与相邻边缘组织中的表达水平的作用。
方法与结果
本研究纳入了35例接受手术切除肿瘤组织的CRC患者。收集肿瘤样本和相邻边缘组织,并通过实时PCR分析基因表达。研究了miR-548aa表达水平与临床参数之间的相关性。我们的研究结果显示,与边缘组织相比,miR-548aa在肿瘤组织中的表达显著增加(p < 0.05)。在CRC样本中显著检测到miR-548aa的上调,曲线下面积为0.89(p = 0.002),表明对CRC诊断具有较强的敏感性和特异性。为了预测miRNA靶基因并构建miR-548aa的调控网络,我们使用了包括TargetScan和miRDB在内的生物信息学工具。通过STRING数据库构建蛋白质-蛋白质相互作用(PPI)网络,并使用Cytoscape软件进行可视化。
结论
miR-548aa的失调与结直肠组织中的肿瘤发生密切相关,这影响疾病进展和临床结果。miR-548aa可作为一种参与肿瘤发生机制、基因靶向和CRC诊断预测价值的生物分子被引入,并且可作为治疗干预的靶点。